News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trophogen, Inc. Selects Advanced BioScience Laboratories, Inc. as Contract Manufacturer for Recombinant, Human Follicle-Stimulating Hormone (rhFSH) Analog


1/10/2012 8:44:26 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--Trophogen Inc., a biotechnology company developing hormone and related growth factor analogs for human infertility, animal superovulation, and human cancers together with Advanced BioScience Laboratories Inc. (ABL), a biomedical contract research and manufacturing organization, today announced the signing of a contract manufacturing agreement between the two companies. The agreement includes the technology transfer and cGMP production of Trophogen’s recombinant, more potent/efficacious and longer acting human follicle-stimulating hormone (rhFSH) analog. The analog is the lead compound developed through Trophogen’s proprietary superagonist hormone technology platform originally licensed from the National Institutes of Health. The program is funded by a National Institute for Child Health & Human Development (NICHD) Phase 2 competitive renewal SBIR grant for $3 million over a 3 year period.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES